Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth
Continuing its efforts to improve its product portfolio, DRRD entered several deals in FY22: 1) the sale of certain non-core brands in India, Russia and CIS; 2) the acquisition of Nimbus Health in Germany to enter niche space of…